Watch Demo

Rx/Reimbursement Adult Incontinence in Austria

Rx/Reimbursement Adult Incontinence in Austria
  • Publish Date:March 2023

  • Number of Pages:19

  • Report ID:5376702

  • Format:PDF

  • Publisher:Euromonitor International

$ 990


The Österreichische Gesundheitskasse (ÖGK) (Austrian health insurance), amended and simplified the regulations for Rx/reimbursement adult incontinence products in 2021. The new rules restrict the number of products to two per day. The health insurance company states that two products per day are sufficient, as incontinence products are increasingly efficient and absorb fluid more effectively.

Rx/Reimbursement adult incontinence in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of contents

Rx/Reimbursement Adult Incontinence in Austria
Euromonitor International
March 2023

List Of Contents And Tables

New regulations restrict product amount to...


Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.